142 related articles for article (PubMed ID: 2455565)
1. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells.
Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y
Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565
[TBL] [Abstract][Full Text] [Related]
2. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
[TBL] [Abstract][Full Text] [Related]
3. Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia.
Tobe H; Ruether BA; Jerry LM; Tamaoki T
Cancer Biochem Biophys; 1986 Oct; 8(4):313-26. PubMed ID: 3492264
[TBL] [Abstract][Full Text] [Related]
4. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells.
Wallgren A; Festin R; Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
Blood; 1993 Aug; 82(4):1230-8. PubMed ID: 8102559
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
6. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
7. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
Rhodes J; Tite J
J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
[TBL] [Abstract][Full Text] [Related]
8. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
10. HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1985 Jun; 15(6):620-6. PubMed ID: 3159585
[TBL] [Abstract][Full Text] [Related]
11. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
12. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
Linner KM; Monroy C; Bach FH; Gehrz RC
Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
[TBL] [Abstract][Full Text] [Related]
13. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
14. Regulation of malignant B-cell proliferation by direct binding of anti-HLA class-II antibodies.
Sauerwein RW; De Rie MA; van der Meer WG; Miedema F; Aarden LA
Cell Immunol; 1988 Jul; 114(2):424-31. PubMed ID: 2455605
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells.
Kabelitz D; Tötterman TH; Nilsson K; Gidlund M
Clin Exp Immunol; 1984 Aug; 57(2):461-6. PubMed ID: 6235991
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
17. Examination of two anti-HLA-DR-like monoclonal antibodies.
Nikolova EB
Haematologia (Budap); 1986; 19(2):133-40. PubMed ID: 2428703
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens.
Nunez G; Ball EJ; Stastny P
Hum Immunol; 1987 May; 19(1):29-39. PubMed ID: 3495523
[TBL] [Abstract][Full Text] [Related]
19. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
20. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
